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Background: Parkinson's disease (PD) is a movement disorder caused by the gradual and 
sustained loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). There is 
presently no permanent treatment for PD, thus the need for more investigations into 
complementary and alternative medicine capable of inhibiting neuronal damage. This study 
investigates the potential neuroprotective activity of Crossyne guttata, a plant commonly found 
in the western and southern Cape of South Africa in 1-methyl-4-phenylpyridinium (MPP+)-
induced, in vitro model of PD, using the SH-SY5Y neuroblastoma cells. Methodology: The 
optimal concentration of Crossyne guttata aqueous extract (CGE) that showed no toxicity on 
cells and the concentration of MPP+ that reduced cell viability to about 50% was determined 
using the 3-(4,5-dimethyithiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. 
Following this SH-SY5Y cells were pretreated with 10 μg/ml of CGE for 2 hours before the 
addition of 2000 μM of MPP+ and cell survival was determined. Furthermore, morphological 
changes associated with treatments were observed under the light microscope. Results: Results 
show that CGE did not reduce cell viability in the cells at all concentrations tested, while MPP+ 
showed a dose-dependent reduction in cell viability. Also, pretreatment of cells with CGE extract 
improved cell survival as well as cell morphology by inhibiting toxicity induced by MPP+. 
Conclusion: Findings from this study suggest that CGE may be a potential neuroprotective agent 
in PD and thus make a case for further investigation into the mechanism(s) of action as well as 
bioactive components of the plant eliciting such effects.  
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INTRODUCTION   
Neurodegenerative diseases (NDDs) play roles in 
mortality and morbidity especially among older people. 
NDDs are a heterogeneous group of diseases, defined by 
the gradual reduction of neuronal cell viability as well as 
quantity of these cells (Pentón-Rol and Cervantes-
Llanos, 2018). One of the common NDDs is Parkinson’s 
diseases among old people with about 1-2% of older 
population over the demonstrating some signs of PD 
(Wood et al., 2010). Parkinson’s disease (PD) is a 
neurodegenerative disorder that involves a loss of    
neurons in a region of the midbrain referred to as the 
substantia nigra pars compacta (SNpc) leading to motor 
and cognitive impairments   (Dauer and Przedborski, 
 
2003, Wirdefeldt et al., 2011, Dexter and Jenner, 2013). 
A neuropathological hallmark of PD is the presence of 
Lewy bodies in neurons, cytosolic inclusions rich in 
fibrillar forms of the presynaptic protein α-synuclein 
(aSyn) (Yasuda and Mochizuki, 2010, Del Tredici and 
Braak, 2012, Macphee and Stewart, 2012).  
At the molecular level, PD is characterized by an 
impairment of the activity of mitochondria complex I, an 
enzyme critical for the progression of the mitochondria 
electron transport chain (Winklhofer and Haass, 2010, 
Choi et al., 2011). Following the inhibition of complex, 
there is increased loss of ATP and generation of reactive 
oxygen species (ROS) which results in accumulation of 
aSyn aggregates around neurons and this in turn, lead to 
cell death (Büeler, 2010, Perier et al., 2012). This is 
particularly heightened as dopaminergic neurons have 
been reported to have high basal amount of ROS 
(Betarbet et al., 2000).  
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Several cellular models have been used to investigate 
PD both in vitro and in vivo with the aid of neurotoxins 
(Beal, 2001, Sherer et al., 2003, Bové et al., 2005). A 
notable neurotoxin is the 1-methyl-4-phenylpyridinium 
(MPP+), which is the toxic metabolite of 1-methyl-
4phenyl-1,2,3,6-tetrahydropyridine (MPTP), a by-
product in the synthesis of 1-methyl-4-phenyl-4-
propionoxy-piperidine (MPPP) (Wolf, 2013). MPPP 
which is a synthetic analogue of a commonly abused 
substance heroin, triggers parkinsonism in humans when 
injected intravenously (Langston et al., 1983). MPTP is 
converted to MPP+ by monoamine oxidase B in non-
neuronal cells, such as glial cells and astrocytes and 
thereafter, MPP+ induces loss of dopaminergic neurons 
via a cascade of events leading to ROS generation and 
ultimately, cell death (Ransom et al., 1987, Brooks et al., 




There is presently no permanent cure for PD as 
current therapies including L-dopa and carbidopa act by 
controlling disease symptoms but do not put a stop to 
underlying degeneration of dopaminergic neurons or 
reverse this process (Connolly and Lang, 2014, Zigmond 
and Smeyne, 2014). Despite the breakthroughs recorded 
in the development of synthetic drugs for NDDs, 
traditional herbal medicine is still of value in most part 
of the world for the treatment of disease conditions, 
owing to their ready availability and cheap cost (Kong et 
al., 2003, Bandaranayake, 2006, WHO, 2005)  
 
 
Medicinal plants provides good source of treatment 
for several illnesses such as neurodegenerative diseases, 
diabetes mellitus and cancers (Ekor, 2014). Africa, 
especially Southern Africa has a rich diversity of plants; 
approximately 25 % of the total number of plants in the 
world, hailing from sub-Saharan Africa (Van Wyk, 
2008). South Africa has a rich flora and a lot of people 
rely on traditional herbal medicine as alternative therapy 
due their accessibility. Many plants used as traditional 
herbal medicine contain compounds such as 
polyphenols, flavonoids, alkaloids and terpenes which 
are capable of scavenging free radicals (Rates, 2001, 
Tiwari, 2008). It is therefore important for medicinal 
plants to be investigated for their potential treatment of 





Crossyne guttata is an indigenous plant of the Cape 
Province belonging to the Amaryllidaceae family. The 
leaf margins are completely fringed with straight short. 
To the best of our knowledge, there is so far, no report 
on the biological activities of this plant hence we provide 
first evidence on the possible biological effects of the 
plant. This study therefore aims to investigate the 
potential neuroprotective effects of Crossyne guttata in 
an in vitro MPP+-SH-SY5Y cellular model of PD. 
METHODS 
Sample collection and extract preparation 
Fresh leaves of Crossyne guttata were harvested, 
washed and air-dried to remove moisture content. 
Thereafter, the dried leaves were reduced to powder and 
about 1 kg of the powdered leaves were soaked in 
boiling water and left overnight for extraction. The 
resultant extract was thereafter filtered with Whatmann 
filter paper and the filtrate evaporated in a freeze dryer 
to obtain a dried powder aqueous Crossyne guttata 
extract (CGE) which was stored at 8 °C until needed. A 
portion of CGE was weighed and dissolved in dimethyl 
sulfoxide (DMSO, Sigma-Aldrich, St Louis MO, USA) 
to give a stock solution of 40 mg/ml from which 
dilutions in media were made for treatment of cells each 
day of experiment. 
 
Cell culture  
The human neuroblastoma SH-SY5Y cells were 
generously donated by the Blackburn Laboratory, 
University of Cape Town. Cells were grown in 
Dulbecco's Modified Eagle's medium (DMEM, Gibco, 
Life Technologies Corporation, Paisley, UK), 
supplemented with 10% fetal bovine serum, (FBS, 
Gibco, Life Technologies Corporation, Paisley, UK), 
100 U/mL penicillin and 100 µg/mL streptomycin 
(Lonza Group Ltd., Verviers, Belgium). Cultures were 
incubated at 37 °C in humidified air with 5% CO2 with a 
medium change every three days. Cells were sub-
cultured when they attained 70 to 80 percent confluency 
using a solution of of 0.25 % trypsin EDTA (Lonza 
Group Ltd., Verviers, Belgium). 
 
Cytotoxicity screening 
The MTT assay was performed to determine the 
optimal concentration of CGE that had no adverse effect 
on cell viability and the concentration of MPP+ (Sigma-
Aldrich, St Louis MO, USA) that induced significant 
toxicity to SH-SY5Y cells. SH-SY5Y cells were plated 
at a density of 100 cells/well and exposed to increasing 
concentrations of CGE ranging from 10, 20, 30, and 40 
µg/ml and vehicle (amount of DMSO in the highest 
concentration of extract) treated cells served as control. 
For MPP+, a 50 mM stock solution was prepared in un-
supplemented DMEM and further dilutions were made 
in supplemented growth medium to arrive at final 
concentrations of 1000 to 2500 µM which were 
introduced to cells, and cells not exposed to MPP+ served 
as control. All treatments lasted for 24 hours. 
 
Cell viability  
Cell viability was evaluated after treatments as stated 
above using the MTT (Sigma-Aldrich, St Louis MO, 
USA) assay. This assay determines mitochondrial 
neuroprotective potentials of Crossyne guttata in MPP+-induced toxicity 
 
140     J. Afr. Ass. Physiol. Sci. 7 (2): 2019                  Omoruyi et al. 
 
 
function of living cells on the basis of their ability to 
reduce the yellow MTT tetrazolium salt into a purple 
formazan crystal mainly by the mitochondrial 
dehydrogenases. For neuroprotection experiment, cells 
were plated in 96 well plates at a density of 10 000 
cells/well and were left overnight to attach. Thereafter, 
cells were pretreated for 2 hours with 10 µg/ml of CGE 
followed by the addition of 2000 µM MPP+. These 
concentrations were obtained from the cytotoxicity 
screening and after 24 hours, 20 µL of the MTT stock 
solution (5mg/mL in PBS) was added to each well and 
left to incubate at 37°C for 4 hours in the dark. At the 
end of the incubation, the medium containing the MTT 
dye was removed and the resulting purple formazan 
formed was solubilized with 100 μL of DMSO. After 
that, absorbance was measured using a microplate reader 
(BMG Labtech Omega® POLARStar) at a wavelength 
570 nm and percentage cell survival was calculated 
relative to control. 
 
Cell morphology 
Cells were plated and treated as stated above in the 
neuroprotection experiment.  At the end of the treatment, 
cell morphology was analyzed in the various treatment 
conditions using the Zeiss inverted light microscope 
with 10X objective lens. Images were captured using the 
Zeiss software version 2.3. 
 
Statistical analysis 
Data generated from this study were analyzed using 
GraphPad Prism 6 and expressed as means and standard 
error of means of three independent experiments 
performed in quadruplicate wells. One-way analysis of 
variance (ANOVA) was used to determine level of 




Effect of CGE on cell survival of SH-SY5Y cells 
The effects of CGE on cell survival was determined 
using the MTT assay by exposing SH-SY5Y cells to 
increasing concentrations of extract (10 to 40 µg/ml) for 
24 hours. The results show that at all concentrations 
tested, CGE had no effect on cell viability (Fig. 1); 
however, the 10 µg/ml concentration was chosen for 
further studies as it improved cell viability slightly above 
the control treated cells albeit not significant. Taken 
together, CGE had no adverse effect on SH-SY5Y cell 
survival at the concentrations tested.  
 
Cytotoxicity of MPP+ on SH-SY5Y cells 
To ascertain the effective concentration of MPP+ that 
induced  less than 50%   neuronal cell death, cells were 
 
Fig. 1. Effect of CGE on SH-SY5Y cells. Cells were exposed 
to concentrations of 10 μg/ml, 20 μg/ml, 30 μg/ml and 40 
μg/ml for 24 hours. Percentage cell survival was determined 
using the MTT assay and expressed relative to the control. 




Cytotoxicity of MPP+ on SH-SY5Y cells 
To ascertain the effective concentration of MPP+ that 
induced less than 50% neuronal cell death, cells were 
treated with 500, 1000, 1500, 2000 and 2500 µM of 
MPP+ for 24 hours. Results obtained shows that at the 
lowest concentration of MPP+ (500 µM), there was no 
significant change in cell viability of SH-SY5Y cells 
when compared to control. In contrast, at higher 
concentrations (1000-2500 µM), MPP+ significantly 
decreased cell viability when compared to control (Fig. 
2). However, 2000 µM of MPP+ was selected for further 
experiments as it reduced cell survival to approximately 
fifty percent (50%). 
 
Crossyne guttata extract mitigate MPP+-induced 
toxicity in SH-SHY5Y cells  
To investigate the neuroprotective effects of CGE in 
MPP+ induced neuronal toxicity, SH-SY5Y cells were 
pretreated with 10 µg/ml of CGE for 2 hours followed 
by the addition of 2000 µM of MPP+ for 24 hours. Fig. 
3 shows that pretreatment of SH-SY5Y cells with CGE 
mitigated against MPP+-induced toxicity. Indeed MPP+ 
reduced cell survival to 47.3%, while pretreatment with 
CGE reversed the effect of MPP in the cells as cell 
survival rose to 78.1%. As expected, cell viability of 
CGE treated cells was similar to control.  Together, these 
findings suggest that CGE may be effective in protecting 
neuronal cells from MPP+-induced toxicity.  
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Fig. 2. MPP+ induce cytotoxicity on SH-SY5Y cells. Cells 
were exposed to concentrations of 500 μM, 1000 μM, 1500 
μM, 2000 μM and 2500 μM for 24 hours. Percentage cell 
survival was determined using the MTT assay and expressed 
relative to the control. Data represent the mean ± SEM of at 
least three independent experiments. 
 
survival rose to 78.1%. As expected, cell viability of 
CGE treated cells was similar to control.  Together, these 
findings suggest that CGE may be effective in protecting 
neuronal cells from MPP+-induced toxicity.  
 
CGE inhibits morphological changes induced by MPP+ 
In order to visualize morphological changes in SH-
SY5Y cells following treatments, cells were treated as 
stated above for neuroprotection and viewed under the 
light microscope. Images obtained show that compared 
to control, MPP+ led to changes in cell morphology 
which could be reminiscent of a cell undergoing 
programmed cell death (Figs 4 A and B). These cellular 
changes include: cell shrinkage as well as loss of 
neuronal projections; however, following pretreatment 
with CGE, an improvement of cell morphology was 
evident (Fig. 4 C). As expected cells exposed to CGE 
alone showed no remarkable change in morphology 
when compared to control (Fig. 4 D). These findings 
suggest that CGE protects SH-SY5Y cells from 
morphological changes induced by MPP+. 
 
DISCUSSION 
Parkinson’s disease is the second most common 
neurodegenerative disorder next to Alzheimer’s disease 
(Elbaz et al., 2016). The exact cause of Parkinson’s 
disease is unknown, but it is assumed to be the result of 
a combination of environmental influences 
superimposed on genetic predisposition or susceptibility  
 
Fig.  3. CGE protects SH-SY5Y cells from MPP+-induced 
toxicity. Cells were pretreated with 10 μg/ml for 2 hours 
followed by the introduction of 2000 μM MPP+ as well as 10 
μg/ml of CGE for 24 hours. Percentage cell survival was 
determined from MTT assays and expressed relative to the 
control. Each bar represents mean ± SEM of at least three 
independent experiments performed in quadruplicates. 
 
(Lees et al., 2009). Since PD is clinically incurable, due 
to the multiple pathologies associated with the disease,if 
untreated, approximately 80% of patients diagnosed of 
the disease become severely disabled after 20 years of 
onset (Iranzo et al., 2013, Connolly and Lang, 2014, 
Elbaz et al., 2016). Thus, it is quite important to develop 
strategies capable of delaying the onset of the disease. 
The present study investigated the neuroprotective 
activity of CGE on MPP+-induced neuronal toxicity on 
SH-SY5Y cells. 
The MPP+-SH-SY5Y cells in vitro PD model is 
widely used for investigating potential neuroprotective 
agents and mechanism of neurodegeneration (Aymerich 
et al., 2016, Zhu et al., 2018, Chanthammachat and 
Dharmasaroja, 2019).  MPP+, upon transportation into 
cells by the dopamine transporter, is concentrated in the 
mitochondria, where it binds NADH dehydrogenase to 
inhibit the electron transport chain (Ramsay et al., 1991). 
MPP+ selectively damages dopaminergic neurons in the 
substantia nigra of the brain due to its inhibitory effect 
on mitochondria complex I, which in turn, reduces ATP 
synthesis and accumulation of ROS (Trist et al., 2019). 
These cascade of events in the dopaminergic neurons 
eventually lead to cell death which shows in clinical 
settings as PD (Büeler, 2010, Perier et al., 2012).   
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Fig. 4. Morphological changes associated with treatment. (A) Untreated cells (B) Cells treated with 2000 µM MPP+ (C) Cells 
pretreated with 10 µg/ml CGE and exposed to 2000 µM MPP+ (D) Cells exposed to 10 µg/ml CGE alone. Images were visualized 
under the light microscope using the 10X objective. 
 
 
In the current study, we show for the first time that 
CGE mitigates MPP+-induced cytotoxicity in SH-SY5Y 
cells and also restores cell morphology in the cells 
exposed to the toxin. Morphological changes in MPP+ 
treated cells could be reminiscent of cells undergoing 
apoptosis but this needs to be confirmed with assays 
investigating apoptosis; however, induction of apoptosis 
is widely known as one of the mechanisms of action of 
MPP+-induced neuronal toxicity in PD models (Zhao et 
al., 2016, Jovanovic-Tucovic et al., 2019, Shishido et al., 
2019).   
While the mechanisms of action of CGE was not 
characterized in this study, it is however worthy to note 
that plant extracts with antioxidant activities have been 
reported to attenuate MPP+-induced toxicities in PD 
models (Abushouk et al., 2017). Zizyphus spina-christi 
fruits, Psephellus pyrrhoblepharus and ginseng extract 
have been reported to inhibit MPP+-induced ROS 
generation and apoptosis in SH-SY5Y cells (Hu et al., 
2011, Singh et al., 2018, Taştan et al., 2019).  
 
CONCLUSION 
This study investigates the potential neuroprotective 
activity of CGE extract in MPP+-SH-SY5Y in vitro 
model of PD. Findings suggest that CGE may be 
effective in the protection of neuronal cells exposed to 
MPP+; however, the potential mechanism(s) of action of 
CGE on PD models should be investigated and the 
possible bioactive compounds promoting 
neuroprotection elucidated.   
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